Powered by

E-Motion Medical Receives CE Mark Approval for Its Novel Stimulation Therapy for Patients With Acute Digestive Dysmotility

Nov 20, 2018 - PR Newswire

PR Newswire

E-Motion Medical Ltd.announced today it has received CE Mark approval for its lead product, the E-Motion System(TM), providing stimulation therapy that restores the natural motor function of the digestive system for patients with acute gastrointestinal dysmotility (GID). Acute GID is common in neurological, trauma, surgical, geriatric and severe diabetic patients. It manifests itself as reduction in, or lack of, motility in the digestive system, and leads to increased risk of c...